Fig. 2From: A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumabFDG-PET/CT and MRI findings. The FDC-PET/CT findings of femurs demonstrate increased 18FDG uptake in the bone marrow at the pelvis and femurs (a, white arrows). The MRI findings of femurs demonstrates low signal intensity on the T1-weighted image (b, yellow arrows) and T2-weighte image (c, white arrowheads) whereas high signal intensity on the STIR image (d, yellow arrowheads). 18FDG = fluorine-18-fluro-deoxyglucose, PET/CT = positron emission tomography/computed tomography, MRI = magnetic resonance imaging, STIR = short T1 inversion recoveryBack to article page